| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |